Senores Pharmaceuticals Ltd Share Price Today - Senores Pharmaceuticals Ltd Stock Price Live NSE/BSE

Senores Pharmaceuticals Ltd

NSE: SENORES BSE: 544319

₹784.25

(1.38%)

Sat, 04 Apr 2026, 05:16 am

MTF 5xInvest in Senores Pharmaceuticals Ltd with 5x Leverage Buy with MTF

Market Cap35.68B

PE Ratio35.55

Dividend0

Health Technology

Pharmaceuticals: Major

24.5K

Senores Pharmaceuticals Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
3617.05
Net Profit
58.34
P/B
3.35
Sector P/E
31.02
P/E
45.03
EV/EBITDA
23.56
Debt/Equity (Industry)
0.26
Interest Cover (Industry)
10.96
ROCE (Industry)
16.65
RONW (Industry)
14.66
ROE
11.78
ROCE
11.75
Debt/Equity
0.58
EPS (TTM)
22.06
Dividend Yield
0
Book Value
176.75
Interest Cover
4.27

Analysis

No Result Found

Financials

Ratios

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	45.80	45.80	45.78	45.77	45.76
FII	3.35	4.28	3.66	4.17	4.25
DII	9.31	8.61	9.51	9.65	11.78
Public	41.54	41.31	41.05	40.40	38.20
Government	0	0	0	0	0

Technical Analysis

RSI

54.81

MACD

-2.00

50 DMA

780.53

200 DMA

732.19

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	946.47	851.07	805.33	755.67	709.93	660.27	564.87
Fibonacci	851.07	814.62	792.11	755.67	719.22	696.71	660.27
Camarilla	785.84	777.09	768.35	755.67	750.86	742.11	733.37

Pivots Level: Classic

+190.80

946.47

+95.40

851.07

+49.67

805.33

755.67

Pivot Point

LTP: 784.25

-45.73

709.93

-95.40

660.27

-190.80

564.87

Moving Average

SMAEMA

Period

Value

10-EMA
763.39
20-EMA
761.57
30-EMA
765.72
50-EMA
772.99
100-EMA
769.46
200-EMA
723.15

Announcement Date	Purpose	Action
20 Jan 2026	board-meetings	Quarterly Results
07 Jan 2026	egm
06 Nov 2025	board-meetings	Quarterly Results
26 Aug 2025	agm

Senores Pharmaceuticals Ltd

Lupin Ltd

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd

Divis Laboratories Ltd

Senores Pharmaceuticals Ltd About

Senores Pharmaceuticals is engaged in the business of manufacturing, marketing and trading of pharmaceuticals and allied products and also providing management and consultancy services.

Industry

Pharmaceuticals - Indian - Formulations

Founded

2017

Headquarters

CEO

Sanjay Majmudar

Employees

Contact

Website

http://www.senorespharma.com

cs@senorespharma.com

Phone

+91-79-2999 9857

Location

#.1101-1103 11th Flr South Twr, Ambali Bopal Road, Ahmedabad, Gujarat, 380054

Year	History
2017	The company was originally incorporated as Senores Pharmaceuticals Private Limited.
2021	Incorporated a wholly owned subsidiary, Senores Pharmaceuticals Inc, in the US. Entered into a new segment of API with the acquisition of Ratnagene Lifescience Private Limited.
2022	Started the domestic business with the launch of critical care injectables.
2023	Changed the company name to Senores Pharmaceuticals Limited upon conversion to a public limited company. Received approval from the central government for the name change. Obtained a fresh certificate of incorporation reflecting the name change.
2024	Launched first CMO product in the US with Jubilant Cadista.

Client Name	Order Side	QTY	Avg Price	Date
ASTORNE CAPITAL VCC ARVEN	Sell	500000	792.12	24 Dec 2025
YASHKUMAR SHANTILAL SANGHVI	Sell	276270	792	24 Dec 2025
RAVI PAWANKUMAR SANGHVI	Sell	292500	792.19	24 Dec 2025
GRAVITON RESEARCH CAPITAL LLP	Sell	316091	689.98	29 Jul 2025
HRTI PRIVATE LIMITED	Buy	269264	686.66	29 Jul 2025
GRAVITON RESEARCH CAPITAL LLP	Buy	316091	689.33	29 Jul 2025
HRTI PRIVATE LIMITED	Sell	237321	688.87	29 Jul 2025
QE SECURITIES LLP	Buy	244396	686.01	24 Jul 2025
GRAVITON RESEARCH CAPITAL LLP	Buy	639285	684.96	24 Jul 2025
GRAVITON RESEARCH CAPITAL LLP	Sell	639285	685.44	24 Jul 2025

Senores Pharmaceuticals Ltd News

Senores Pharmaceuticals Forms US Joint Venture

Senores Pharmaceuticals Limited announces strategic joint venture Amerisyn, LLC in the United States to access federal government and defense sector supply contracts through its subsidiary SPI.

04 Apr 2026

companies

Senores Pharmaceuticals Forms US Joint Venture

Senores Pharmaceuticals Limited announces strategic joint venture Amerisyn, LLC in the United States to access federal government and defense sector supply contracts through its subsidiary SPI.

03 Apr 2026

companies

Senores Pharma Files SAST Disclosure for Warrant Allotment

Senores Pharmaceuticals files regulatory disclosure under SEBI SAST regulations for allotment of 11,70,000 convertible warrants worth ₹95.00 crore to promoter group entities.

01 Apr 2026

companies

Senores Pharma Allots 11.70 Lakh Warrants Worth ₹95 Cr

Senores Pharmaceuticals completes allotment of 11,70,000 convertible warrants at ₹812 per warrant to promoters and promoter group entities, raising ₹95.00 crore through preferential issue.

28 Mar 2026

companies

Senores Pharma Allots 11.70 Lakh Warrants Worth ₹95 Cr

Senores Pharmaceuticals completes allotment of 11,70,000 convertible warrants at ₹812 per warrant to promoters and promoter group entities, raising ₹95.00 crore through preferential issue.

28 Mar 2026

companies

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800